Disk galaxies are self-similar: the universality of the HI-to-Halo mass ratio for isolated disks

Observed scaling relations in galaxies between baryons and dark matter global properties are key to shed light on the process of galaxy formation and on the nature of dark matter. Here, we study the scaling relation between the neutral hydrogen (HI) and dark matter mass in isolated rotationally-supported disk galaxies at low redshift. We first show that state-of-the-art galaxy formation simulations predict that the HI-to-dark halo mass ratio decreases with stellar mass for the most massive disk galaxies. We then infer dark matter halo masses from high-quality rotation curve data for isolated disk galaxies in the local Universe, and report on the actual universality of the HI-to-dark halo mass ratio for these observed galaxies. This scaling relation holds for disks spanning a range of 4 orders of magnitude in stellar mass and 3 orders of magnitude in surface brightness. Accounting for the diversity of rotation curve shapes in our observational fits decreases the scatter of the HI-to-dark halo mass ratio while keeping it constant. This finding extends the previously reported discrepancy for the stellar-to-halo mass relation of massive disk galaxies within galaxy formation simulations to the realm of neutral atomic gas. Our result reveals that isolated galaxies with regularly rotating extended HI disks are surprisingly self-similar up to high masses, which hints at mass-independent self-regulation mechanisms that have yet to be fully understood.Comment: 14 pages, 4 figures. Accepted for publication in ApJ

Modelling the strongest silicate emission features of local type 1 AGN

We measure the 10 and $18\mu$m silicate features in a sample of 67 local ($z<0.1$) type 1 active galactic nuclei (AGN) with available {\it Spitzer} spectra dominated by non-stellar processes. We find that the $10\mu$m silicate feature peaks at $10.3^{+0.7}_{-0.9}\mu$m with a strength (Si$_{p}$ = ln f$_{p}$(spectrum)/f$_{p}$(continuum)) of $0.11^{+0.15}_{-0.36}$, while the $18\mu$m one peaks at $17.3^{+0.4}_{-0.7}\mu$m with a strength of $0.14^{+0.06}_{-0.06}$. We select from this sample sources with the strongest 10$\mu$m silicate strength ($\sigma_{Si_{10\mu m}}>0.28$, 10 objects). We carry out a detailed modeling of the IRS/{\it Spitzer} spectra by comparing several models that assume different geometries and dust composition: a smooth torus model, two clumpy torus models, a two-phase medium torus model, and a disk+outflow clumpy model. We find that the silicate features are well modeled by the clumpy model of Nenkova et al. 2008, and among all models those including outflows and complex dust composition are the best (Hoenig et al. 2017). We note that even in AGN-dominated galaxies it is usually necessary to add stellar contributions to reproduce the emission at the shortest wavelengths.Comment: Accepted for publication in Ap

Absence of nuclear polycyclic aromatic hydrocarbon emission from a compact starburst: the case of the type-2 quasar Mrk 477

Mrk 477 is the closest type-2 quasar, at a distance of 163 Mpc. This makes it an ideal laboratory for studying the interplay between nuclear activity and star formation with a great level of detail and signal-to-noise. In this Letter we present new mid-infrared (mid-IR) imaging and spectroscopic data with an angular resolution of 0.4″ (∼300 pc) obtained with the Gran Telescopio Canarias instrument CanariCam. The N-band (8–13 μm) spectrum of the central ∼400 pc of the galaxy reveals [S IV]λ10.51 μm emission, but no 8.6 or 11.3 μm polycyclic aromatic hydrocarbon (PAH) features, which are commonly used as tracers of recent star formation. This is in stark contrast with the presence of a nuclear starburst of ∼300 pc in size, an age of 6 Myr, and a mass of 1.1×108 M⊙, as constrained from ultraviolet Hubble Space Telescope observations. Considering this, we argue that even the more resilient, neutral molecules that mainly produce the 11.3 μm PAH band are most likely being destroyed in the vicinity of the active nucleus despite the relatively large X-ray column density, log NH = 23.5 cm−2, and modest X-ray luminosity, 1.5×1043 erg s−1. This highlights the importance of being cautious when using PAH features as star formation tracers in the central region of galaxies to evaluate the impact of feedback from active galactic nuclei

The Galaxy Activity, Torus, and Outflow Survey (GATOS): III. Revealing the inner icy structure in local active galactic nuclei

We use JWST/MIRI MRS spectroscopy of a sample of six local obscured type 1.9/2 active galactic nuclei (AGN) to compare their nuclear mid-IR absorption bands with the level of nuclear obscuration traced by X-rays. This study is the first to use subarcsecond angular resolution data of local obscured AGN to investigate the nuclear mid-IR absorption bands with a wide wavelength coverage (4.9–28.1 μm). All the nuclei show the 9.7 μm silicate band in absorption. We compare the strength of the 9.7 and 18 μm silicate features with torus model predictions. The observed silicate features are generally well explained by clumpy and smooth torus models. We report the detection of the 6 μm dirty water ice band (i.e., a mix of water and other molecules such as CO and CO2) at subarcsecond scales (∼0.26″ at 6 μm; inner ∼50 pc) in a sample of local AGN with different levels of nuclear obscuration in the range log NHX-Ray (cm−2)∼22 − 25. We find good correlation between the 6 μm water ice optical depths and NHX-Ray. This result indicates that the water ice absorption might be a reliable tracer of the nuclear intrinsic obscuration in AGN. The weak water ice absorption in less obscured AGN (log NHX-ray (cm−2)≲23.0 cm−2) might be related to the hotter dust temperature (> TsubH2O ∼ 110 K) expected to be reached in the outer layers of the torus due to their more inhomogeneous medium. Our results suggest it might be necessary to include the molecular content, such as H2O, aliphatic hydrocarbons (CH−), and more complex polycyclic aromatic hydrocarbon (PAH) molecules, in torus models to better constrain key parameters such as the torus covering factor (i.e., nuclear obscuration)

EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015

Table of contents A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value of “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy, not for 99 % unhealthy Russell J. Andrews A5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentials Babak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. Mozaffari A6 Specific diets for personalised treatment of diabetes type 2 Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. Boyko A7 Towards personalized physiotherapeutic approach Joanna Bauer, Ewa Boerner, Halina Podbielska A8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseases Alojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. Boyko A9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solution Hans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose Verdu A10 PPPM in cardiovascular medicine in 2015 Hans-Peter Brunner-La Rocca A11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development – pilot results Rostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. Spivak A12 Ultrasound diagnosis for diabetic neuropathy - comparative study Rostyslav V. Bubnov, Tetyana V. Ostapenko A13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and personalized treatment - pilot results Rostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola Ya. Spivak A14 Project ImaGenX – designing and executing a questionnaire on environment and lifestyle risk of breast cancer John Paul Cauchi A15 Genomics – a new structural brand of predictive, preventive and personalized medicine or the new driver as well? Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey Suchkov A16 Survey of questionnaires for evaluation of the quality of life in various medical fields Barbara Cieślik, Agnieszka Migasiewicz, Maria-Luiza Podbielska, Markus Pelleter, Agnieszka Giemza, Halina Podbielska A17 Personalized molecular treatment for muscular dystrophies Sebahattin Cirak A18 Secondary mutations in circulating tumour DNA for acquired drug resistance in patients with advanced ALK + NSCLC Marzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi, Carmine Pinto, Marcello Tiseo, Romano Danesi A19 Recombinant species-specific FcεRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and horses Lukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger, Josef Singer, Erika Jensen-Jarolim A20 Global methodology for developmental neurotoxicity testing in humans and animals early and chronically exposed to chemical contaminants Arpiné A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut, Torsten Bonn, Cédric Guignard, Margherita Ferrante, Maria Liusa Chiusano, Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat, Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves, Oscar Villacañas Pérez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin Haranta, Nina Zaitseva, Irina May, Stéphanie Grojean, Mathilde Body-Malapel, Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja, Vittorio Calabrese, Christophe Nemos, Rachid Soulimani A21 Mental indicators at young people with attributes hypertension and pre-hypertension Maria E. Evsevyeva, Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A. Smirnova A22 On the approaches to the early diagnosis of stress-induced hypertension in young employees of State law enforcement agencies Maria E. Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. Rostovtseva A23 Сentral aortic pressure and indexes of augmentation in young persons in view of risk factors Maria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V. Sergeeva, Nadesgda M. Konovalova A24 Breast cancer prediction and prevention: Are reliable biomarkers in horizon? Shantanu Girotra, Olga Golubnitschaja A25 Flammer Syndrome and potential formation of pre-metastatic niches: A multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease Olga Golubnitschaja, Manuel Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M. Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna Konieczka A26 Innovative tools for prenatal diagnostics and monitoring: improving individual pregnancy outcomes and health-economy in EU Olga Golubnitschaja, Jan Jaap Erwich, Vincenzo Costigliola, Kristina Yeghiazaryan, Ulrich Gembruch A27 Immunohistochemical assessment of APUD cells in endometriosis Vadym M. Goncharenko, Vasyl O. Beniuk, Olga V. Kalenska, Rostyslav V. Bubnov A28 Updating personalized management algorithm of endometrial hyperplasia in pre-menopause women Vadym M. Goncharenko, Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga Melnychuk A29 The personified treatment approach of polimorbid patients with periodontal inflammatory diseases Irina A. Gorbacheva, Lyudmila Y. Orekhova, Vadim V. Tachalov A30 Ukrainian experience in hybrid war – the challenge to update algorithms for personalized care and early prevention of different military injuries Olena I. Grechanyk, Rizvan Ya. Abdullaiev, Rostyslav V. Bubnov A31 Tear fluid biomarkers: a comparison of tear fluid sampling and storage protocols Suzanne Hagan, Eilidh Martin, Ian Pearce, Katherine Oliver A32 The correlation of dietary habits with gingival problems during menstruation Cenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin, Natalia S. Moiseeva A33 Genomic medicine in a contemporary Spanish population of prostate cancer: our experience Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-Cruz A34 Challenges, opportunities and collaborations for personalized medicine applicability in uro-oncological disease Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara A35 Metabolic hallmarks of cancer as targets for a personalized therapy John Ionescu A36 Influence of genetic polymorphism as a predictor of the development of periodontal disease in patients with gastric ulcer and 12 duodenal ulcer Alfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh. Magomedov, Aida I. Isamulaeva A37 Challenges in diabetic macular edema Tatjana Josifova A38 Overview of the EPMA strategies in laboratory medicine relevant for PPPM Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja, Vincenzo Costigliola A39 EPMA initiative for effective organization of medical travel: European concepts and criteria Vincenzo Costigliola, Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja A40 Design and innovation in e-textiles: implications for PPPM Anthony Kent, Tom Fisher, Tilak Dias A41 Biobank in Pilsen as a member of national node BBMRI_CZ Judita Kinkorová, Ondřej Topolčan A42 Big data in personalized medicine: hype and hope Matthias Kohl A43 The 3P approach as the platform of the European Dentistry Department (DPPPD) Anatoly A. Kunin, Natalia S. Moiseeva A44 The endometrium cytokine patterns for predictive diagnosis of proliferation severity and cancer prevention Andrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko, Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. Strokan A45 A monocyte-based in-vitro system for testing individual responses to the implanted material: future for personalized implant construction Julia Kzhyshkowska, Alexandru Gudima, Ksenia S. Stankevich, Victor D. Filimonov4, Harald Klüter, Evgeniya M. Mamontova, Sergei I. Tverdokhlebov A46 Prediction and prevention of adverse health effects by meteorological factors: Biomarker patterns and creation of a device for self-monitoring and integrated care Ulyana B. Lushchyk, Viktor V. Novytskyy, Igor P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. Legka A47 Targeting "disease signatures" towards personalized healthcare Mira Marcus-Kalish, Alexis Mitelpunkt, Tal Galili, Neta Shachar, Yoav Benjamini A48 Influence of the skin imperfection on the personal quality of life and possible tools for objective diagnosis Agnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dereń, Halina Podbielska A49 The new direction in caries prevention based on the ultrastructure of dental hard tissues and filling materials Natalia S. Moiseeva, Anatoly A. Kunin, Dmitry A. Kunin A50 The use of LED radiation in prevention of dental diseases Natalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N. Morozov, Natalia V. Chirkova, Nakhid T. Aliev A51 Status of endothelial progenitor cells in diabetic nephropathy: predictive and preventive potentials Mahmood S. Mozaffari, Jun Yao Liu, Babak Baban A52 The status of glucocorticoid-induced leucine zipper protein in salivary gland in Sjögren’s syndrome: predictive and personalized treatment potentials Mahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi, Babak Baban A53 Maximal aerobic capacity - important quality marker of health Jaroslav Novák, Milan Štork, Václav Zeman A54 The EMPOWER project: laboratory medicine and Horizon 2020 Wytze P. Oosterhuis, Elvar Theodorsson A55 Personality profile manifestations in patient’s attitude to oral care and adherence to doctor’s prescriptions Lyudmila Y. Orekhova, Tatyana V. Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. Loboda A56 Results of an European survey on personalized medicine addressed to directions of laboratory medicine Mario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik, Gerard Siest, Elvar Theodorsson, Chiara Di Resta A57 MCI or early dementia predictive speech based diagnosis techniques Matus Pleva, Jozef Juhar A58 Personalized speech based mobile application for eHealth Matus Pleva, Jozef Juhar A59 Circulating tumor cell-free DNA as the biomarker in the management of cancer patients Jiří Polívka jr., Filip Janků, Martin Pešta, Jan Doležal, Milena Králíčková, Jiří Polívka A60 Complex stroke care – educational programme in Stroke Centre University Hospital Plzen Jiří Polívka, Alena Lukešová, Nina Müllerová, Petr Ševčík, Vladimír Rohan A61 Sleep apnea and sleep fragmentation contribute to brain aging Kneginja Richter, Lence Miloseva, Günter Niklewski A62 Personalised approach for sleep disturbances in shift workers Kneginja Richter, Jens Acker, Guenter Niklewski A63 Medical travel and innovative PPPM clusters: new concept of integration Olga Safonicheva, Vincenzo Costigliola A64 Medical travel and women health Olga Safonicheva A65 Continuity of generations in the training of specialists in the field of reconstructive microsurgery Maxim Sautin, Janna Sinelnikova, Sergey Suchkov A66 Telemonitoring of stroke patients – empirical evidence of individual risk management results from an observational study in Germany Songül Secer, Stephan von Bandemer A67 Women’s increasing breast cancer risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive effect on DNA damage: implications for gender-specific nutrition within personalized medicine Niva Shapira A68 Cytobacterioscopy of the gingival crevicular fluid as a method for preventive diagnosis of periodontal diseases Aleksandr Shcherbakov, Anatoly A. Kunin, Natalia S. Moiseeva A69 Use of specially treated composites in dentistry to avoid violations of aesthetics Bogdan R. Shumilovich, Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. Sudareva A70 National eHealth system – platform for preventive, predictive and personalized diabetes care Ivica Smokovski, Tatjana Milenkovic A72 The common energy levels of Prof. Szent-Györgyi, the intrinsic chemistry of melanin, and the muscle physiopathology. Implications in the context of Preventive, Predictive, and Personalized Medicine Arturo Solís-Herrera, María del Carmen Arias-Esparza, Sergey Suchkov A73 Plurality and individuality of hepatocellular carcinoma: PPPM perspectives Krishna Chander Sridhar, Olga Golubnitschaja A74 Strategic aspects of higher medical education reforms to secure newer educational platforms for getting biopharma professionals matures Maria Studneva, Sihong Song, James Creeden, Мark Мandrik, Sergey Suchkov A75 Overview of the strategies and activities of the European Federation of Clinical Chemistry and Laboratory Medicine, (EFLM) Elvar Theodorsson, EFLM A76 New spectroscopic techniques for point of care label free diagnostics Syed A. M. Tofail A77 Tumor markers for personalized medicine and oncology - the role of Laboratory Medicine Ondřej Topolčan, Judita Kinkorová, Ondřej Fiala, Marie Karlíková, Šárka Svobodová, Radek Kučera, Radka Fuchsová, Vladislav Třeška, Václav Šimánek, Ladislav Pecen, Jan Šoupal, Štěpán Svačina2 A78 Modern medical terminology (MMT) as a driver of the global educational reforms Evgeniya Tretyak, Maria Studneva, Sergey Suchkov A79 Juvenile hypertension; the relevance of novel predictive, preventive and personalized assessment of its determinants Francesca M. Trovato, G. Fabio Martines, Daniela Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. Trovato A80 Proteomarkers Biotech George Th. Tsangaris, Athanasios K. Anagnostopoulos A81 Proteomics and mass spectrometry based non-invasive prenatal testing of fetal health and pregnancy complications George Th. Tsangaris, Athanasios K. Anagnostopoulos A82 Integrated Ecosystem for an Integrated Care model for Heart Failure (HF) patients including related comorbidities (ZENITH) José Verdú, German Gutiérrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera, Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel Vara, on behalf of ZENITH consortium A83 Predictive, preventive and personalized medicine in diabetes onset and complication (MOSAIC project) José Verdú, Francesco Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico, Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of MOSAIC consortium A84 Possibilities for personalized therapy of diabetes using in vitro screening of insulin and oral hypoglycemic agents Igor Volchek, Nina Pototskaya, Andrey Petrov A85 The innovative technology for personalized therapy of human diseases based on in vitro drug screening Igor Volchek, Nadezhda Pototskaya, Andrey Petrov A86 Bone destruction and temporomandibular joint: predictive markers, pathogenetic aspects and quality of life Ülle Voog-Oras, Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagomägi, Minh Son Nguyen, Chris Pruunsild, Dagmar Piikov, Mare Saag A87 Sub-optimal health management – global vision for concepts in medical travel Wei Wang A88 Sub-optimal health management: synergic PPPM-TCAM approach Wei Wang A89 Innovative technologies for minimal invasive diagnostics Andreas Weinhäusel, Walter Pulverer, Matthias Wielscher, Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan, Ronald Kulovics, Silvia Schönthaler, Gabriel Beikircher, Albert Kriegner, Stephan Pabinger, Klemens Vierlinger A90 Rare disease diobanks for personalized medicine Ayşe Yüzbaşıoğlu, Meral Özgüç, Member of EuroBioBank - European Network of DNA, Cell and Tissue Banks for Rare Disease

The dust-gas AGN torus as constrained from X-ray and mid-infrared observations

Context. In recent decades, several multiwavelength studies have been dedicated to exploring the properties of the obscuring material in active galactic nuclei (AGN). Various models have been developed to describe the structure and distribution of this material and constrain its physical and geometrical parameters through spectral fitting techniques. However, questions around the way in which torus mid-infrared (mid-IR) and X-ray emission are related remain unanswered. Aims. In this work, we aim to study whether the dust continuum at mid-IR and gas reflection at X-rays have the same distribution in a sample of AGN. Methods. We carefully selected a sample of 36 nearby AGN with NuSTAR and Spitzer spectra available that satisfy the following criteria: (1) the AGN component dominates the mid-IR spectra (i.e., the stellar and interstellar medium components contribute less than 50% to the spectrum), and (2) the reflection component contributes significantly to the X-ray spectrum. Furthermore, we discarded the sources whose reflection component could be produced by ionized material in the disk. We derived the properties of the nuclear dust and gas through a spectral fitting, using models developed for mid-IR and X-ray wavelengths assuming smooth and clumpy distributions for this structure. Results. We find that a combination of smooth and clumpy distributions of gas and dust, respectively, is preferred for ∼80% of sources with good spectral fits according to the Akaike criterion. However, considering extra information about each individual source, such as the absorption variability, we find that ∼50% of our sources are best described by a clumpy distribution of both dust and gas. The remaining ∼50% of our sources can still be explained with a smooth distribution of gas and a clumpy distribution of dust. Furthermore, we explored the torus dust-to-gas ratio, finding that it is [0.01–1] times that of the interstellar medium. Conclusions. The results presented in this paper suggest that the distribution of the gas and dust in AGN is complex. We find at least six scenarios to explain the observed properties of our sample. In these scenarios, three gas–dust distribution combinations are possible: clumpy–clumpy, smooth–smooth, and smooth–clumpy. Most of them are in agreement with the notion that gas could also be located in the dust-free region, which is consistent with the dust-to-gas ratio found

Observational hints on the torus obscuring gas behaviour through X-rays with NuSTAR data

According to theory, the torus of active galactic nuclei (AGN) is sustained from a wind coming off the accretion disc, and for low efficient AGN, it has been proposed that such structure disappears. However, the exact conditions for its disappearance remain unclear. This can be studied throughout the reflection component at X-rays, which is associated with distant and neutral material at the inner walls of the torus in obscured AGN. We select a sample of 81 AGNs observed with NuSTAR with a distance limit of D23⁠), with ∼20 per cent being Compton-thick. We also find an increase in the number of unobscured sources and a tentative increase on the ratio between FeKα emission line and Compton-hump luminosities toward λEdd=10−5⁠, suggesting that the contribution of the FeKα line changes with Eddington ratio. © 2021 The Author(s). Published by Oxford University Press on behalf of Royal Astronomical SocietyThis research has made use of the NASA/IPAC Extragalactic Data base (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration. This research has made use of data and/or software provided by the High Energy Astrophysics Science Archive Research Center (HEASARC), which is a service of the Astrophysics Science Division at NASA/GSFC and the High Energy Astrophysics Division of the Smithsonian Astrophysical Observatory. NOC would like to thank CONACyT scholarship No. 897887. CVC acknowledges support from CONACyT. We thank the UNAM PAPIIT project IN105720 (PI OGM). LHG acknowledges funds by ANID – Millennium Science Initiative Program – ICN12_009 awarded to the Millennium Institute of Astrophysics (MAS).With funding from the Spanish government through the Severo Ochoa Centre of Excellence accreditation SEV-2017-0709.Peer reviewe